StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
22
This month
1
This year
4
Publishing Date
2024 - 04 - 02
1
2024 - 03 - 11
1
2024 - 02 - 05
1
2024 - 01 - 24
1
2023 - 12 - 01
1
2022 - 03 - 16
1
2022 - 02 - 15
2
2022 - 02 - 14
1
2022 - 02 - 11
1
2022 - 01 - 25
2
2021 - 12 - 20
2
2021 - 12 - 13
1
2021 - 12 - 10
1
2021 - 12 - 09
1
2021 - 12 - 07
1
2021 - 12 - 06
1
2021 - 12 - 03
1
2021 - 11 - 24
1
2021 - 11 - 19
1
Sector
Health technology
18
Manufacturing
4
N/a
1
Process industries
1
Tags
Acquisition
112
Als
61
America
34
Biopharma
47
Biotech-beach
51
Biotechnology
41
Business
52
Cancer
76
Cel
35
Ces
163
Collaboration
37
Conference
247
Contract
35
Corporation
58
Covid
34
Deal
41
Disease
40
Drug
51
Earnings
48
Ema
41
Energy
70
Events
129
Fda
68
Financial
99
Financial results
58
First
41
Genetown
57
Global
91
Group
62
Growth
63
Health
97
Iot
36
Market
218
Million
52
N/a
2774
Nasdaq
38
Offering
54
One
53
Partnership
41
People
59
Pharm-country
43
Platform
42
Positive
37
Program
51
Reach
49
Report
168
Research
184
Results
215
Security
37
Set
41
Solutions
36
Spac
46
Study
35
System
48
Technology
75
Therapeutics
141
Therapy
37
Treatment
72
Trial
75
Year
57
Entities
Abbott laboratories
1
Ac immune sa
1
Amyris, inc.
1
Anixa biosciences, inc.
1
Arcturus therapeutics holdings inc.
1
Astellas pharma inc
1
Astrazeneca plc
1
Biontech se
1
Capricor therapeutics, inc.
2
Csl ltd
1
Geovax labs, inc.
1
Glaxosmithkline plc
1
Immunitybio inc
1
Johnson & johnson
2
Moderna, inc.
2
Novavax, inc.
3
Nrx pharmaceuticals inc
2
Sanofi
3
Thermo fisher scientific inc
1
Vaxxinity, inc.
1
Vbi vaccines, inc.
1
Symbols
ABT
1
ACIU
1
ALPMF
1
ALPMY
1
AMRS
1
ANIX
1
ARCT
1
AZN
1
AZNCF
1
BNTX
1
CAPR
2
CMXHF
1
CSLLY
1
GLAXF
1
GOVX
1
GSK
1
IBRX
1
JNJ
2
MRNA
2
NRXP
2
NVAX
3
SNY
3
SNYNF
3
TMO
1
VAXX
1
VBIV
1
Exchanges
Nasdaq
19
Nyse
4
Crawled Date
2024 - 04 - 02
1
2024 - 03 - 11
1
2024 - 02 - 05
1
2024 - 01 - 24
1
2023 - 12 - 01
1
2022 - 03 - 16
1
2022 - 02 - 15
2
2022 - 02 - 14
1
2022 - 02 - 11
1
2022 - 01 - 25
2
2021 - 12 - 20
2
2021 - 12 - 13
1
2021 - 12 - 10
1
2021 - 12 - 09
1
2021 - 12 - 07
1
2021 - 12 - 06
1
2021 - 12 - 03
1
2021 - 11 - 24
1
2021 - 11 - 19
1
Crawled Time
00:00
26
00:20
13
01:00
20
02:00
6
03:00
6
04:00
2
05:00
11
06:00
34
07:00
32
08:00
10
08:01
2
08:20
2
09:00
30
09:36
7
10:00
25
11:00
104
11:01
2
12:00
199
12:03
2
12:15
25
12:20
24
12:30
22
13:00
162
13:02
3
13:03
4
13:04
2
13:06
2
13:15
34
13:20
28
13:30
36
13:59
4
14:00
118
14:01
5
14:04
3
14:12
7
14:15
21
14:20
25
14:30
22
15:00
101
15:15
21
15:20
11
15:30
14
16:00
77
16:01
2
16:04
2
16:20
5
17:00
88
17:01
2
17:04
2
18:00
71
19:00
55
19:01
2
19:07
7
19:25
2
20:00
46
21:00
50
22:00
58
22:01
3
22:16
5
23:00
54
Source
www.biospace.com
13
www.globenewswire.com
7
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Vaccine
crawled time :
14:30
save search
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
Published:
2024-04-02
(Crawled : 14:30)
- biospace.com/
VBIV
|
$0.591
-4.68%
-4.91%
370K
|
Health Technology
|
Email alert
Add to watchlist
partnership
vaccine
platform
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published:
2024-03-11
(Crawled : 14:30)
- prnewswire.com
CMXHF
|
$175.0
-19.21%
110
|
n/a
|
-5.41%
|
O:
0.41%
H:
0.0%
C:
0.0%
CSLLY
|
$87.83
3.3%
48K
|
n/a
|
-6.8%
|
O:
-4.92%
H:
3.76%
C:
3.44%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-5.92%
|
O:
-3.4%
H:
1.49%
C:
1.49%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.19%
|
O:
1.55%
H:
0.82%
C:
0.16%
ALPMY
|
News
|
$9.34
-1.11%
690K
|
Manufacturing
|
-12.05%
|
O:
-1.41%
H:
5.06%
C:
4.01%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-8.21%
|
O:
-0.6%
H:
0.19%
C:
0.09%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-10.65%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.06%
|
O:
0.57%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.65%
|
O:
1.08%
H:
0.82%
C:
0.67%
pharma
vaccine
astrazeneca
research
key
market
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster - February 5, 2024
Published:
2024-02-05
(Crawled : 14:30)
- biospace.com/
ARCT
4
|
$27.68
-8.13%
-8.85%
620K
|
Health Technology
|
-13.22%
|
O:
-0.29%
H:
2.11%
C:
1.3%
covid-19
vaccine
mrna
therapeutics
results
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
Published:
2024-01-24
(Crawled : 14:30)
- globenewswire.com
CAPR
|
$5.57
-6.07%
-6.46%
480K
|
Health Technology
|
43.58%
|
O:
2.18%
H:
6.4%
C:
-3.32%
vaccine
sars-cov-2
collaboration
trial
therapeutics
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster S...
Published:
2023-12-01
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.06%
|
O:
1.39%
H:
0.0%
C:
-0.05%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
0.04%
|
O:
0.93%
H:
0.0%
C:
0.0%
vaccine
rsv
market
COVID-19 Isn’t Done with Us Yet, Vaccine Patents and a 4th Booster
Published:
2022-03-16
(Crawled : 14:30)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-16.49%
|
O:
1.23%
H:
0.0%
C:
0.0%
covid-19
patent
covid
one
vaccine
BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide an Update on Sustainable Vaccine Manufacturing in Africa
Published:
2022-02-15
(Crawled : 14:30)
- globenewswire.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.75%
|
O:
1.0%
H:
0.99%
C:
0.47%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-44.13%
|
O:
0.85%
H:
5.72%
C:
4.87%
conference
vaccine
marburg
africa
AC Immune ACI-35.030 Phase 1b/2a Trial Interim Data Confirm Consistent Safety and Potent Immunogenicity of pTau Alzheimer’s Vaccine in High-dose Cohort
Published:
2022-02-15
(Crawled : 14:30)
- globenewswire.com
ACIU
|
$2.45
0.0%
250K
|
Health Technology
|
-43.55%
|
O:
2.07%
H:
3.61%
C:
1.58%
aci-35
alzheimer
phase 1b
trial
phase 1
aci-35.030
vaccine
alzheimer’s
alzheimer's
phase 2b
Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland
Published:
2022-02-14
(Crawled : 14:30)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-95.68%
|
O:
-3.44%
H:
2.07%
C:
-7.82%
covid-19
covid
authorization
switzerland
vaccine
Vaxxinity’s COVID-19 Vaccine Candidate UB-612 Produces High Levels of Neutralizing Antibodies Against Omicron and Other Variants of Concern
Published:
2022-02-11
(Crawled : 14:30)
- globenewswire.com
VAXX
|
$0.418
-4.96%
-5.22%
310K
|
|
-93.46%
|
O:
3.74%
H:
0.0%
C:
0.0%
covid-19
xin
covid
vaccine
antibody
Thermo Fisher Scientific Earns NSF/ANSI 456 Vaccine Storage Certification for its High-Performance Refrigerators and Freezers
Published:
2022-01-25
(Crawled : 14:30)
- biospace.com/
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
-4.96%
|
O:
-1.25%
H:
1.47%
C:
-0.15%
vaccine
perform
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
Published:
2022-01-25
(Crawled : 14:30)
- biospace.com/
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
|
4.97%
|
O:
0.33%
H:
3.96%
C:
1.32%
patent
ovarian cancer
bioscience
cancer
vaccine
ImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing
Published:
2021-12-20
(Crawled : 14:30)
- biospace.com/
IBRX
|
$5.25
6.71%
6.29%
4.3M
|
Manufacturing
|
-19.88%
|
O:
1.53%
H:
1.2%
C:
-2.41%
AMRS
|
$0.05
-21.88%
-16.36%
47M
|
Process Industries
|
-98.83%
|
O:
-2.79%
H:
1.93%
C:
-3.72%
als
bladder cancer
trials
trial
covid
cel
clinical trials
cancer
vaccine
phase 3
merge
t-cell
bladder
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Published:
2021-12-20
(Crawled : 14:30)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-98.11%
|
O:
11.76%
H:
2.83%
C:
-12.2%
covid-19
europe
covid
authorization
positive
vaccine
Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19
Published:
2021-12-13
(Crawled : 14:30)
- biospace.com/
CAPR
|
$5.57
-6.07%
-6.46%
480K
|
Health Technology
|
90.06%
|
O:
-1.92%
H:
0.0%
C:
0.0%
covid-19
therapeutics
covid
vaccine
Moderna Announces Additional 20 Million Doses of COVID-19 Vaccine to COVAX for Supply in 2021 and New Additional Supply Agreement for 2022
Published:
2021-12-10
(Crawled : 14:30)
- biospace.com/
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
-63.79%
|
O:
-17.85%
H:
0.0%
C:
0.0%
covid-19
covid
vaccine
NRx Pharmaceuticals and Hungarian Health Officials Agree on Pathway for ZYESAMI® and BriLife COVID-19 Vaccine Trials
Published:
2021-12-09
(Crawled : 14:30)
- globenewswire.com
NRXP
|
News
0 d
|
$4.17
-3.02%
-3.12%
91K
|
Manufacturing
|
-29.63%
|
O:
0.67%
H:
5.85%
C:
-3.34%
covid-19
zyesami
health
trials
trial
covid
vaccine
brilife
Janssen Announces Respiratory Syncytial Virus (RSV) Adult Vaccine Candidate Maintains High Efficacy Regardless of Lower Respiratory Tract Disease Severity
Published:
2021-12-07
(Crawled : 14:30)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.78%
|
O:
2.13%
H:
0.0%
C:
0.0%
respiratory
disease
vaccine
NRx Announces Completion of Data Safety Meeting for Phase 2 Trial of BriLife Vaccine, Phase 2b/3 Registration Trial to Begin in Nation of Georgia, Israel, European Union, and Other Regions
Published:
2021-12-06
(Crawled : 14:30)
- globenewswire.com
NRXP
|
News
0 d
|
$4.17
-3.02%
-3.12%
91K
|
Manufacturing
|
-24.0%
|
O:
-1.09%
H:
0.0%
C:
0.0%
israel
phase 2
europe
phase 2b
trial
vaccine
brilife
GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress
Published:
2021-12-03
(Crawled : 14:30)
- globenewswire.com
GOVX
|
$1.49
-2.61%
-2.68%
29K
|
Health Technology
|
-62.76%
|
O:
-2.3%
H:
2.06%
C:
-3.66%
immunotherapy
therapy
vaccine
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.